Barclays’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
142,681
+40,891
| +40% | +$415K | ﹤0.01% | 2437 |
|
|
2025
Q1 | $569K | Sell |
101,790
-12,902
| -11% | -$72.1K | ﹤0.01% | 2766 |
|
|
2024
Q4 | $927K | Buy |
114,692
+7,431
| +7% | +$60.1K | ﹤0.01% | 2679 |
|
|
2024
Q3 | $1.1M | Buy |
107,261
+56,474
| +111% | +$579K | ﹤0.01% | 2567 |
|
|
2024
Q2 | $359K | Buy |
50,787
+17,633
| +53% | +$125K | ﹤0.01% | 2721 |
|
|
2024
Q1 | $455K | Sell |
33,154
-21,045
| -39% | -$289K | ﹤0.01% | 2891 |
|
|
2023
Q4 | $499K | Buy |
54,199
+46,484
| +603% | +$428K | ﹤0.01% | 3000 |
|
|
2023
Q3 | $47K | Sell |
7,715
-57
| -0.7% | -$347 | ﹤0.01% | 3624 |
|
|
2023
Q2 | $61K | Buy |
+7,772
| New | +$61K | ﹤0.01% | 3591 |
|
|
2022
Q2 | – | Sell |
-5,252
| Closed | -$29K | – | 4859 |
|
|
2022
Q1 | $29K | Buy |
+5,252
| New | +$29K | ﹤0.01% | 4199 |
|